Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Medtronic Vascular
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Symptomatic coronary artery disease including subjects with chronic stable angina, silent ischemia, and acute coronary syndromes including non-ST elevation and ST-elevation myocardial infarction
Subject is an acceptable candidate for treatment with a drug eluting stent in accordance with the applicable guidelines on percutaneous coronary interventions, manufacturer's Instructions for Use, and the Declaration of Helsinki
Subject requires treatment of a single de novo bifurcated lesion amenable to treatment with Resolute Onyx using the provisional stenting technique
You may not be if
Unprotected left main disease
Subjects with planned PCI of three vessel disease
Planned two stent technique (main branch and side branch) of a bifurcation
Subjects with more than one bifurcation lesion
Clareo Health | RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)
